61 – 70 of 365
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Efficacy of lixisenatide in patients with type 2 diabetes : A post hoc analysis of patients with diverse β-cell function in the GetGoal-M and GetGoal-S trials
(
- Contribution to journal › Article
-
Mark
Efficacy and safety of liraglutide added to capped insulin treatment in subjects with type 1 diabetes : The adjunct two randomized trial
(
- Contribution to journal › Article
-
Mark
Insulin resistance is accompanied by increased fasting glucagon and delayed glucagon suppression in individuals with normal and impaired glucose regulation
(
- Contribution to journal › Article
-
Mark
CART is overexpressed in human type 2 diabetic islets and inhibits glucagon secretion and increases insulin secretion
(
- Contribution to journal › Article
- 2015
-
Mark
Glucagon-early breakthroughs and recent discoveries.
(
- Contribution to journal › Scientific review
-
Mark
Creative use of novel glucose-lowering drugs for type 2 diabetes: where will we head in the next 50 years?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Hepato-Incretin Function of GLP-1: Novel Concept and Target in Type 1 Diabetes.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Physiological aspects of the combination of insulin and GLP-1 in the regulation of blood glucose control.
(
- Contribution to journal › Article
-
Mark
DPP-4 inhibition contributes to the prevention of hypoglycaemia through a GIP-glucagon counterregulatory axis in mice.
(
- Contribution to journal › Article
-
Mark
Deciphering the hypoglycemic glucagon response: development of a graded hyperinsulinemic hypoglycemic clamp technique in female mice.
(
- Contribution to journal › Article